Oversight and Management of Women with Psoriasis in Childbearing Age
- PMID: 35744043
- PMCID: PMC9227010
- DOI: 10.3390/medicina58060780
Oversight and Management of Women with Psoriasis in Childbearing Age
Abstract
Psoriasis is a complex disease with many associated comorbidities, all of which have a negative impact on a patient's personal, social, and sexual life. There are some unique considerations in the effects of this disease among women. The average age of diagnosis in women with psoriasis is 28 years, and this onset corresponds to the fertile life of women. There is conflicting information about the effects of psoriasis on female fertility. Some studies suggest that this condition's associated comorbidities, personal behaviors, and reduced ovarian reserve, especially due to chronic inflammation, affect women's fertility. Another possible reason women with psoriasis are less likely to become pregnant is that their sexual intercourse frequency decreases after the condition's onset. The available information on the effects of pregnancy on women with psoriasis is limited. According to current evidence, most women will experience an improvement in their skin condition. Studies show that patients with moderate-to-severe psoriasis are more prone to experience pregnancy complications. The management of pregnant and lactating women with psoriasis is also difficult, as the safety profile of commonly used drugs in patients with psoriasis is not entirely known.
Keywords: biologic agents; breastfeeding; management; outcome; pregnancy; psoriasis; topical/systemic drugs; treatment; women.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
Planifier une grossesse chez une patiente avec un psoriasis.Eur J Dermatol. 2020 Oct 1;30(S1):18-24. doi: 10.1684/ejd.2020.3886. Eur J Dermatol. 2020. PMID: 33242005 English.
-
Treatment of psoriasis and psoriatic arthritis during pregnancy and breastfeeding.An Bras Dermatol. 2015 May-Jun;90(3):367-75. doi: 10.1590/abd1806-4841.20153113. An Bras Dermatol. 2015. PMID: 26131868 Free PMC article. Review.
-
Certolizumab Pegol in Plaque Psoriasis: Considerations for Pregnancy.Skin Therapy Lett. 2021 Mar;26(2):1-5. Skin Therapy Lett. 2021. PMID: 33769772 Review.
-
Management of moderate to severe plaque psoriasis in pregnancy and lactation in the era of biologics.Acta Dermatovenerol Alp Pannonica Adriat. 2014;23(2):27-31. doi: 10.15570/actaapa.2014.7. Acta Dermatovenerol Alp Pannonica Adriat. 2014. PMID: 24964946
-
Pregnancy Outcomes in Women With Moderate-to-Severe Psoriasis From the Psoriasis Longitudinal Assessment and Registry (PSOLAR).JAMA Dermatol. 2021 Mar 1;157(3):301-306. doi: 10.1001/jamadermatol.2020.5595. JAMA Dermatol. 2021. PMID: 33533924 Free PMC article.
Cited by
-
The Perspective of Cannabidiol in Psoriasis Therapy.Psoriasis (Auckl). 2024 Jun 19;14:51-61. doi: 10.2147/PTT.S469698. eCollection 2024. Psoriasis (Auckl). 2024. PMID: 38911997 Free PMC article. Review.
-
The Expanding Therapeutic Potential of Deucravacitinib Beyond Psoriasis: A Narrative Review.J Clin Med. 2025 Mar 5;14(5):1745. doi: 10.3390/jcm14051745. J Clin Med. 2025. PMID: 40095888 Free PMC article. Review.
-
Pharmacovigilance Pregnancy Data in a Population of Japanese Patients With Chronic Inflammatory Disease Exposed to Certolizumab Pegol.Int J Rheum Dis. 2025 Jan;28(1):e70048. doi: 10.1111/1756-185X.70048. Int J Rheum Dis. 2025. PMID: 39812078 Free PMC article.
-
Psoriasis in Childbearing Age: A Real-Life, Retrospective, Single-Center Study on Anti-IL17 and IL-23 Agents.J Clin Med. 2024 Oct 25;13(21):6401. doi: 10.3390/jcm13216401. J Clin Med. 2024. PMID: 39518540 Free PMC article.
-
Impact of Psoriasis on Pregnancy Desire and Possible Consequences on Fertility.Dermatol Pract Concept. 2024 Oct 30;14(4):e2024221. doi: 10.5826/dpc.1404a221. Dermatol Pract Concept. 2024. PMID: 39652941 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical